ICU MEDICAL INC/DE (ICUI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 900M 1.8B 2.7B FY07: 188.1M FY08: 204.7M FY09: 229M FY10: 283M FY11: 302.2M FY12: 316.9M FY13: 313.7M FY14: 309.3M FY15: 341.7M FY16: 379.4M FY17: 1.3B FY18: 1.4B FY19: 1.3B FY20: 1.3B FY21: 1.3B FY22: 2.3B FY23: 2.3B FY24: 2.4B FY25: 2.2B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 300M 600M 900M FY07: 78.2M FY08: 89.8M FY09: 106.3M FY10: 129M FY11: 142.4M FY12: 156.5M FY13: 154.7M FY14: 151.4M FY15: 180.8M FY16: 201.4M FY17: 426.1M FY18: 570M FY19: 471.9M FY20: 461.5M FY21: 491.5M FY22: 697.8M FY23: 739.9M FY24: 824.8M FY25: 822M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-50M 0 50M 100M 150M FY07: 24.6M FY08: 31.4M FY09: 35.4M FY10: 47.7M FY11: 65.2M FY12: 61.3M FY13: 51.9M FY14: 39M FY15: 68.6M FY16: 82.9M FY17: -13.3M FY18: 29.8M FY19: 107.4M FY20: 98.2M FY21: 123.2M FY22: -42.9M FY23: 22.8M FY24: 43M FY25: 42.8M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY07: 23.1M FY08: 24.3M FY09: 25M FY10: 29.9M FY11: 44.7M FY12: 41.3M FY13: 40.4M FY14: 26.3M FY15: 45M FY16: 63.1M FY17: 68.6M FY18: 28.8M FY19: 101M FY20: 86.9M FY21: 103.1M FY22: -74.3M FY23: -29.7M FY24: -117.7M FY25: 732K FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 600M 1.2B 1.8B FY16: 178M FY17: 866.5M FY18: 830M FY19: 794.3M FY20: 809.5M FY21: 824.8M FY22: 1.6B FY23: 1.5B FY24: 1.6B FY25: 1.4B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-100M 0 100M 200M 300M FY07: 41.5M FY08: 30.3M FY09: 51.1M FY10: 33.1M FY11: 64.5M FY12: 66.3M FY13: 65.7M FY14: 66.3M FY15: 64.2M FY16: 89.9M FY17: 154.4M FY18: 160.2M FY19: 101.9M FY20: 222.8M FY21: 267.5M FY22: -62.1M FY23: 166.2M FY24: 204M FY25: 179.8M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-210M -140M -70M 0 70M 140M 210M FY07: 17.9M FY08: 19M FY09: 34.4M FY10: 9.9M FY11: 48.7M FY12: 47.1M FY13: 47.3M FY14: 49.7M FY15: 51.2M FY16: 66.6M FY17: 79.9M FY18: 67.5M FY19: 4.6M FY20: 130.7M FY21: 199M FY22: -152.4M FY23: 82.3M FY24: 124.7M FY25: 91.8M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 9M 18M 27M FY07: 15.3M FY08: 14.6M FY09: 15M FY10: 13.9M FY11: 14.2M FY12: 14.7M FY13: 15.3M FY14: 15.6M FY15: 16.5M FY16: 17.3M FY17: 20.9M FY18: 21.6M FY19: 21.5M FY20: 21.6M FY21: 21.8M FY22: 23.9M FY23: 24.1M FY24: 24.4M FY25: 24.9M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '08: 1.66 Q1 '09: 1.93 Q2 '09: 1.98 Q3 '09: 1.88 Q4 '09: 1.67 Q1 '10: 1.50 Q2 '10: 1.68 Q3 '10: 1.91 Q4 '10: 2.21 Q1 '11: 2.48 Q2 '11: 2.59 Q3 '11: 2.59 Q4 '11: 3.15 Q1 '12: 3.11 Q2 '12: 3.07 Q3 '12: 3.24 Q4 '12: 2.80 Q1 '13: 2.85 Q2 '13: 2.70 Q3 '13: 2.60 Q4 '13: 2.64 Q1 '14: 2.49 Q2 '14: 2.39 Q3 '14: 2.09 Q4 '14: 1.69 Q1 '15: 1.86 Q2 '15: 2.31 Q3 '15: 2.87 Q4 '15: 2.74 Q1 '16: 3.22 Q2 '16: 3.37 Q3 '16: 3.48 Q4 '16: 3.69 Q1 '17: 5.47 Q2 '17: 2.62 Q3 '17: 1.54 Q4 '17: 3.33 Q1 '18: 0.70 Q2 '18: 4.01 Q3 '18: 4.01 Q4 '18: 1.32 Q1 '19: 2.53 Q2 '19: 2.15 Q3 '19: 3.38 Q4 '19: 4.70 Q1 '20: 4.04 Q2 '20: 3.86 Q3 '20: 3.78 Q4 '20: 4.03 Q1 '21: 4.34 Q2 '21: 4.77 Q3 '21: 5.04 Q4 '21: 4.74 Q1 '22: 2.04 Q2 '22: 0.42 Q3 '22: -1.56 Q4 '22: -3.11 Q1 '23: -1.91 Q2 '23: -2.01 Q3 '23: -1.16 Q4 '23: -1.23 Q1 '24: -2.45 Q2 '24: -2.92 Q3 '24: -4.57 Q4 '24: -4.84 Q1 '25: -3.84 Q2 '25: -1.53 Q3 '25: -0.32 Q4 '25: 0.03 Q1 '26: 1.86 Q2 '26: 1.19 Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.